Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8818477 | Preventive Medicine Reports | 2018 | 5 Pages |
Abstract
HPV prevalence in FSWs was 25.0% and in NFSWs 29.4% (pâ¯=â¯0.14). NFSW had more often untypable HPV-genotypes (HPV-X:5.3% vs 0.0%; pâ¯=â¯0.042). A trend for statistical difference was observed in HPV prevalence between FSWs from Dominican Republic (42.1%) and FSWs from Colombia (19.2%; pâ¯=â¯0.067). Young age was the only risk factor related to HPV prevalence in FSWs. (Mean age FSW 29.2â¯y ±7.8 and NFSW 33â¯y ±6.2) Smoking and drugs consumption were significantly higher among FSW. A significant higher number of women with history of any STD was reported by NFSWs. In addition, >90% of FSW had their previous Pap smear <3â¯years ago, while >35% NFSW never had a previous Pap smear (pâ¯<â¯0.001).In conclusion: no significant difference in HPV prevalence is observed between FSW and NFSW. HPV prevalence in FSW was associated with a lower age. During interviews, FSW seemed more aware about prevention strategies, reported less history of STD's and were more updated with cervical cancer screening, compared to NFSWs.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Desiree J. Hooi, Wim G.V. Quint, Birgit I. Lissenberg-Witte, Gemma Kenter, Herbert M. Pinedo, Maurits N.C. de Koning, Chris J.L.M. Meijer,